Depression (Antidepressant) Drugs Market Size, Share, Analysis, Top Key Players, Forecast Report 2022-2027

The latest report by IMARC Group, titled "Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on the global depression drugs market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global depression drugs market size reached US$ 17.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 21.4 Billion by 2027, exhibiting a growth rate (CAGR) of 3.62% during 2022-2027.

Depression drugs, alternatively referred to as antidepressant, refers to several medicines that treat major depressive disorder, anxiety issues, panic disorder, obsessive-compulsive disorder, and other issues. They can be of various types, such as atypical antipsychotics, serotonin-norepinephrine reuptake inhibitors (SNRIs), central nervous system (CNS) stimulants, tricyclic antidepressants, monoamine oxidase inhibitors, etc. These depression drugs balance the functioning of neurotransmitters in the brain and control the mood and emotions of the patient. They prove effective in relieving the signs of anxiety, dysthymia, and seasonal affective disorder. Consequently, depression drugs are in extensive demand among consumers across the globe.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐍𝐨𝐭𝐞: 𝐖𝐞 𝐚𝐫𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐨𝐟 𝐮𝐩𝐝𝐚𝐭𝐢𝐧𝐠 𝐨𝐮𝐫 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 (𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟖). 𝐈𝐟 𝐲𝐨𝐮 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐫𝐞𝐜𝐞𝐢𝐯𝐞 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐝𝐚𝐭𝐚 𝐜𝐨𝐯𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐭𝐢𝐦𝐞 𝐩𝐞𝐫𝐢𝐨𝐝 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟐𝟖, 𝐚𝐥𝐨𝐧𝐠 𝐰𝐢𝐭𝐡 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐂𝐨𝐬𝐭 𝐌𝐨𝐝𝐮𝐥𝐞, 𝐚𝐧𝐝 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐅𝐫𝐞𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭. 𝐓𝐡𝐞 𝐭𝐞𝐚𝐦 𝐰𝐨𝐮𝐥𝐝 𝐛𝐞 𝐚𝐛𝐥𝐞 𝐭𝐨 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐯𝐞𝐫𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧 𝐚 𝐪𝐮𝐢𝐜𝐤 𝐭𝐮𝐫𝐧𝐚𝐫𝐨𝐮𝐧𝐝 𝐭𝐢𝐦𝐞.

Request Free Sample Report: https://www.imarcgroup.com/depression-drugs-market/requestsample

Global Depression Drugs Market Trends:

The escalating prevalence of social anxiety, depression, and other mental illnesses, on the account of hectic lifestyles, long working hours, stressful work, social isolation, etc., and the expanding awareness about the benefits of seeking professional help are primarily driving the depression drugs market. In addition to this, the elevating advancements in the neurobiology of depression over the past few years and the launch of multiple novel techniques for the development of antidepressants with minimum side effects and long-term results are acting as significant growth-inducing factors.

In line with this, the growing focus among key market players on the introduction of novel pharmacologic and non-pharmacologic interventions is also positively influencing the global market. Apart from this, the increasing collaborations between numerous leading research institutes and pharmaceutical companies to develop advanced products that will exhibit higher success rates and the rising acceptance of new medications are expected to propel the depression drugs market in the coming years.

Explore the Full Report with TOC & List of Figures: https://www.imarcgroup.com/depression-drugs-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

Some of these key players include:

• Otsuka Pharmaceutical
• Pfizer
• Eli Lilly and Company
• AstraZeneca
• Novartis
• Bristol-Myers Squibb
• GlaxoSmithKline
• Takeda Pharmaceutical Company
• Allergan
• Johnson & Johnson
• Zhejiang NHU Company Ltd
• Sebela Pharmaceuticals

Key Market Segmentation:

Market Breakup by Drug Class:

• Atypical Antipsychotics
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Central Nervous System (CNS) Stimulants
• Tricyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Others

Market Breakup by Disorder Type:

• Major Depressive Disorder
• Obsessive-Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others

Market Breakup by Drug Type:

• Generic Drugs
• Branded Drugs

Market Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Explore the Latest Research Reports by IMARC Group:

• Irritable Bowel Syndrome Treatment Market Report: https://www.imarcgroup.com/irritable-bowel-syndrome-treatment-market

• Flavonoids Market Report: https://www.imarcgroup.com/flavonoids-market

• Keystroke Dynamics Market Report: https://www.imarcgroup.com/keystroke-dynamics-market

• Seismic Services Market Report: https://www.imarcgroup.com/seismic-services-market

• Transplant Diagnostics Market Report: https://www.imarcgroup.com/transplant-diagnostics-market

• Public Safety Analytics Market Report: https://www.imarcgroup.com/public-safety-analytics-market

• Topical Pain Relief Market Report: https://www.imarcgroup.com/topical-pain-relief-market

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.